We are live on ! Find out more
NFT

Nan Fung Trinity Portfolio holdings

AUM $1.01B
1-Year Est. Return 64.38%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+64.38%
3 Year Est. Return
+82.31%
5 Year Est. Return
+69.52%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$260M
Cap. Flow
+$231M
Cap. Flow %
18.28%
Top 10 Hldgs %
34.47%
Holding
89
New
18
Increased
31
Reduced
4
Closed
11

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$33.3M
2
KT icon
KT
KT
+$27.8M
3
AMD icon
Advanced Micro Devices
AMD
+$19.9M
4
MP icon
MP Materials
MP
+$17.9M
5
UNH icon
UnitedHealth
UNH
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.24%
2 Technology 15.47%
3 Communication Services 13.78%
4 Consumer Discretionary 10.13%
5 Materials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
26
Freeport-McMoran
FCX
$86.2B
$17.4M 1.38%
+341,700
New +$14.8M
UNH icon
27
UnitedHealth
UNH
$382B
$17.3M 1.37%
+52,435
New +$17.8M
CDTX
28
DELISTED
Cidara Therapeutics
CDTX
$17M 1.35%
+77,100
New +$12.5M
BRKR icon
29
Bruker
BRKR
$9.4B
$16.7M 1.33%
+355,300
New +$15M
BZ icon
30
Kanzhun
BZ
$7.19B
$16.6M 1.31%
814,000
HON icon
31
Honeywell
HON
$76.4B
$16.4M 1.3%
83,900
-556
-0.7% -$109K
PYPL icon
32
PayPal
PYPL
$49.9B
$16.3M 1.29%
278,700
HD icon
33
Home Depot
HD
$337B
$16.2M 1.28%
+46,959
New +$17.2M
XHB icon
34
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
$16M 1.26%
+155,040
New +$16.5M
PTGX icon
35
Protagonist Therapeutics
PTGX
$8.55B
$15.8M 1.25%
180,670
+35,778
+25% +$2.93M
IMNM icon
36
Immunome
IMNM
$2.62B
$15.3M 1.22%
714,553
+122,450
+21% +$2.15M
ACN icon
37
Accenture
ACN
$106B
$15.3M 1.22%
57,200
ABVX
38
Abivax
ABVX
$10.4B
$15.3M 1.21%
113,365
+12,000
+12% +$1.31M
WBD icon
39
Warner Bros
WBD
$64.3B
$14.3M 1.14%
+497,266
New +$11.6M
MP icon
40
MP Materials
MP
$6.78B
$14.3M 1.13%
+283,050
New +$17.9M
INTC icon
41
Intel
INTC
$413B
$14.2M 1.12%
384,300
-280,100
-42% -$10.6M
ORCL icon
42
Oracle
ORCL
$339B
$12.8M 1.01%
65,600
+11,200
+21% +$2.67M
PDD icon
43
Pinduoduo
PDD
$126B
$12.3M 0.97%
108,100
ARE icon
44
Alexandria Real Estate Equities
ARE
$9.37B
$11.7M 0.93%
238,981
+63,032
+36% +$3.71M
SRRK icon
45
Scholar Rock
SRRK
$5.88B
$11.6M 0.92%
263,245
+225,603
+599% +$8.46M
TRVI icon
46
Trevi Therapeutics
TRVI
$2.57B
$11.5M 0.91%
917,450
+827,875
+924% +$9.57M
SVRA icon
47
Savara
SVRA
$1.08B
$10.2M 0.81%
+1,688,500
New +$8.27M
XENE icon
48
Xenon Pharmaceuticals
XENE
$6.1B
$10.2M 0.81%
226,965
+68,360
+43% +$2.87M
META icon
49
Meta Platforms (Facebook)
META
$1.49T
$10M 0.79%
+15,200
New +$10.2M
KURA icon
50
Kura Oncology
KURA
$793M
$10M 0.79%
964,880
+734,000
+318% +$7.7M

Similar funds

Nan Fung Trinity's Q4 2025 Portfolio in Review

As of Q4 2025, Nan Fung Trinity held 89 positions worth $1.26B, up 26% from $1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nan Fung Trinity deployed $231M of net new capital in Q4 2025, opening 18 new positions and adding to 31 existing holdings. Its largest new stake was iShares MBS ETF: 349,200 shares worth $33.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.

  • Nan Fung Trinity's largest Q4 2025 buy was iShares MBS ETF: 349,200 shares worth $33.3M.
  • Nan Fung Trinity added most to Advanced Micro Devices in Q4 2025, an estimated $19.9M increase.
  • Nan Fung Trinity's biggest Q4 2025 reduction was Intel, cutting an estimated $10.6M.
  • Nan Fung Trinity fully exited State Street SPDR S&P Regional Banking ETF in Q4 2025, selling an estimated $33.7M.
  • Nan Fung Trinity's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2025.
  • Nan Fung Trinity opened 18 new positions and closed 11 in Q4 2025.
  • Nan Fung Trinity's portfolio value rose 26% quarter-over-quarter to $1.26B.

Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.